Awarded
Hepatitis B (HBV) vaccine for children and adults 2027-2029 (2029-2030,2030-2031)
Track this recordFree account — get alerted when a contract here runs out.
- Winners
- GlaxoSmithKline Oy
- Contract value
- €2,556,000
- Bids received
- 2
- Published
- 25 Sept 2026
- Awarded
- 22 Sept 2026
- Contract start
- 22 Sept 2026
- Contract end
- 23 Sept 2027estimated
- Region
- Helsinki-Uusimaa
More awards from this buyer
| Awarded | Buyer | Winner | Contract value | Published |
|---|---|---|---|---|
| Measles, mumps and rubella (MMR) vaccine 2027-2028 (2029, 2030) | Ministry of Social Affairs and Health | MSD Finland Oy | €5,097,600 | 7 Sept 2026 |
| Pentavalent (DTaP-IPV+Hib) vaccine 2027-2028 (2029, 2030, 2031) | Ministry of Social Affairs and Health | Sanofi Oy | €11,088,000 | 7 Sept 2026 |